Society guideline links: Classic and nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately.

●(See "Society guideline links: Adrenal insufficiency".)

●(See "Society guideline links: Polycystic ovary syndrome".)

●(See "Society guideline links: Hirsutism".)

●(See "Society guideline links: Differences of sex development".)

International

●Endocrine Society (ES): Clinical practice guideline for the evaluation and treatment of hirsutism in premenopausal women (2018)

●ES: Clinical practice guideline on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency (2018)

United States

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on screening and management of the hyperandrogenic adolescent (2019, reaffirmed 2020)

Europe

●European Molecular Genetics Quality Network (EMQN): Best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency (2020)